Skip to content
DataLookout
Menu

NCT06413134

KPAP Adherence Crossover Study

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved 12 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 5 versions: 5 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Dec 1, 2026 to Dec 1, 2027 Show 5 more changesShow less
    • Start date: Jul 1, 2026 to Feb 1, 2027
    • Eligibility criteria expanded, about 12 words
    • Study completion pushed from Dec 31, 2026 to Dec 31, 2027
    • Secondary endpoints: details revised at 5 of 5 entries
    • Study description expanded, about 16 words
  2. Notable Trial status: Withdrawn to Not Yet Recruitingv4 Show 9 more changesShow less
    • Primary completion date: Aug 1, 2025 to Dec 1, 2026
    • Start date: Dec 10, 2024 to Jul 1, 2026
    • Enrollment target: 0 to 30
    • Study completion date: Sep 1, 2025 to Dec 31, 2026
    • Interventions: APAP (Device), TheraPAP (Device) to APAP (Device), KPAP (Device)
    • Secondary endpoints: details revised at 5 of 5 entries
    • Study description expanded, about 65 words
    • Site contact updated
    • Study title revised
  3. Stopped Trial status: Not Yet Recruiting to Withdrawn Sponsor's reason: This was supposed to be a pilot, single center study, which has been de-prioritized. A larger study will be conducted instead
    • Enrollment target: estimated 32 to confirmed 0
    • Site contact updated
    v3
  4. Notable Primary completion date: Dec 1, 2024 to Aug 1, 2025
    • Start date: May 10, 2024 to Dec 10, 2024
    • Study completion date: Jan 15, 2025 to Sep 1, 2025
    • Secondary endpoints: details revised at 2 of 5 entries
    v2
  5. Study First Submitted
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed

Endpoints

Primary

Usage
Timeframe: Averaged over every night for each 4-week arm

Secondary (5)

ESS Questionnaire
FOSQ-10 Questionnaire
Excess Leak or Leak
P95/P90
AHI

Arms and interventions

4-weeks breathing on APAPPlacebo comparator

Patients will breathe on APAP for 4 weeks simulating normal therapy. Usage, leak, P95/P90 and AHI will be recorded and averaged over the duration.

4-weeks breathing on KPAPExperimental

Patients will breathe on TheraPAP for 4 weeks, which is the therapy under evaluation. Usage, leak, P95/P90 and AHI will also be recorded and averaged over the duration.

Devices: KPAP, APAP

Sites

1 site in 1 country

  • Sleep Centers of Middle TennesseeMurfreesboro, Tennessee, United States